CrossrefInfokarte
Salvage Yttrium-90 Transarterial Radioembolization Combined with Second-Line Molecular Targeted Agents and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Progressing After TACE-Based Combination Therapy: A Single-Center Real-World Study
Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-15
DOI: 10.2147/jhc.s638164 ↗Abstract
Kein Abstract verfügbar.
EUVIMED